In particular, in gastric, esophageal squamous cell, and cervical cancers, IGF2BP3 levels are significantly elevated, showing a strong correlation with lymph node metastasis and poorer prognosis [27,28,29,30]. This evidence concerns the gene IGF2BP3 and cervical cancer.